Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2023-05-25
2023-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is aimed to investigate the safety of minimal fasting time (2 hours) compared to the standard fasting time (4 hours) with gastric ultrasound.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children
NCT05724550
Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541
Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children
NCT01757899
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
NCT04850456
Sugammadex Dose Finding Under Two Years Old
NCT06575036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4H
Participants who are following the standard fasting time (4 hours).
4 hours of fasting time
Oral intake is not allowed for 4 hours before sedation including water.
2H
Participants who are following minimized fasting time (2 hours)
2 hours of fasting time
Oral intake is not allowed for 2 hours before sedation including water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4 hours of fasting time
Oral intake is not allowed for 4 hours before sedation including water.
2 hours of fasting time
Oral intake is not allowed for 2 hours before sedation including water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for elective cardiac echocardiography
Exclusion Criteria
* patients taking medication that delay gastric emptying
* structural deformities, or abnormalities that interrupt gastric ultrasound
* refuse to participate in the study
* sedation is failed or impossible
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Eunah Cho, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eunah Cho, MD
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jinyoung Song
Seoul, Gangnam, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NPO2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.